dr. hammers on study of hyperacute renal immunotherapy in rcc
Published 7 years ago • 59 plays • Length 1:51Download video MP4
Download video MP3
Similar videos
-
0:56
dr. hammers on next steps with immunotherapy in rcc
-
1:17
dr. hammers on the future of immunotherapy in rcc
-
1:17
dr. hammers on the checkmate-214 study for rcc
-
1:21
dr. hammers on the long-term benefits of the checkmate-214 study in rcc
-
1:20
dr. hammers on immunotherapy combinations in kidney cancer
-
1:27
dr. hammers on nivolumab/ipilimumab data in rcc
-
1:18
dr. hammers on challenges with car t-cell therapy in rcc
-
1:37
dr. hammers on combinations of ido and pd-1 inhibitors in rcc
-
1:23
dr. lee on immunotherapy's future in rcc
-
2:09
dr. hammers discusses immunotherapy in rcc
-
1:42
dr. hammers on combination strategies in kidney cancer
-
1:37
dr. choueiri on synergy between immunotherapy and vegf inhibitors in rcc
-
3:03
adjuvant pembrolizumab improves rcc disease-free survival | toni choueiri
-
1:58
dr. plimack on significance of checkmate-025 trial in rcc
-
1:10
dr. motzer on first-line treatment of metastatic rcc
-
1:37
dr. hammers discusses combining ido and pd-1 inhibitors in rcc
-
1:52
dr. powles on monitoring immunotherapy effects in patients with rcc
-
38:09
understanding and working with new immunotherapeutic and targeted management models in advanced rcc
-
1:21
dr. hammers on combination of vaccines and immune checkpoint inhibitors in rcc